Hironori Nagahara

Title: Hironori Nagahara: Innovator in Pharmaceutical Preparations

Introduction

Hironori Nagahara is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug preparations. With a total of 2 patents, his work has the potential to enhance the efficacy and safety of various medications.

Latest Patents

Nagahara's latest patents include a rocuronium preparation with improved stability. This invention provides a rocuronium preparation that contains rocuronium and a buffer solution, with an adjusted pH of 3.5 or less, ensuring excellent stability. The buffer solution can be a citric acid-sodium hydroxide buffer solution, a tartaric acid-sodium hydroxide buffer solution, or other similar solutions. This preparation demonstrates a generation rate of rocuronium-related substance C of 5% or less after six months of storage at 40°C. Another significant patent is an agent for stabilizing acetaminophen in an aqueous composition, which comprises glycine and at least one kind of sulfurous acid salt. This agent effectively prevents precipitation, enhancing the stability of acetaminophen.

Career Highlights

Hironori Nagahara is currently associated with Maruishi Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations to ensure better patient outcomes.

Collaborations

Nagahara collaborates with esteemed colleagues, including Yutaka Itsuji and Keisuke Jinbo, to advance research and development in pharmaceutical preparations.

Conclusion

Hironori Nagahara's contributions to pharmaceutical innovations, particularly in drug stability, highlight his role as a key inventor in the industry. His patents reflect a commitment to enhancing medication safety and efficacy, which is crucial for patient care.